Wells Fargo Bank N.A. Doc re. Publication of Pricing Supplement

RNS Number : 4979D

Wells Fargo Bank N.A.

16 February 2024

 

Publication of Pricing Supplement

The pricing supplement of Wells Fargo Bank, National Association dated 8 February 2024 (the "Pricing Supplement") for the issue of U.S.$20,000,000 zero coupon callable notes due 16 February 2034 (ISIN XS2764433053) under its U.S.$10,000,000,000 euro medium term note programme is available for viewing.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/4979D_1-2024-2-16.pdf

 

For further information, please contact

Sandra Galvis

Senior Lead Counsel & Executive Director

Wells Fargo & Company

[e-mail]

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Pricing Supplement and/or the information memorandum dated 18 September 2023 relating to the above-mentioned programme (as supplemented, the "Information Memorandum") may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Pricing Supplement and/or the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Pricing Supplement and/or the Information Memorandum is not addressed. Prior to relying on the information contained in the Pricing Supplement and/or the Information Memorandum you must ascertain from the Pricing Supplement and/or the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

PSPUNAVRSRUUAAR